Real World Effectiveness of Atezolizumab and Bevacizumab: What Lessons Can We Learn?

Aparna Kalyan; Amit Singal

doi:10.1016/j.jceh.2023.05.009

Real World Effectiveness of Atezolizumab and Bevacizumab: What Lessons Can We Learn?

Aparna Kalyan, Amit Singal^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	553-555
Number of pages	3
Journal	Journal of Clinical and Experimental Hepatology
Volume	13
Issue number	4
DOIs	https://doi.org/10.1016/j.jceh.2023.05.009
State	Published - Jul 1 2023

ASJC Scopus subject areas

Hepatology

Access to Document

10.1016/j.jceh.2023.05.009

Cite this

@article{abfdcfb1f26b43819ca43a31fbb13dd3,

title = "Real World Effectiveness of Atezolizumab and Bevacizumab: What Lessons Can We Learn?",

author = "Aparna Kalyan and Amit Singal",

year = "2023",

month = jul,

day = "1",

doi = "10.1016/j.jceh.2023.05.009",

language = "English (US)",

volume = "13",

pages = "553--555",

journal = "Journal of Clinical and Experimental Hepatology",

issn = "0973-6883",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - Real World Effectiveness of Atezolizumab and Bevacizumab

T2 - What Lessons Can We Learn?

AU - Kalyan, Aparna

AU - Singal, Amit

PY - 2023/7/1

Y1 - 2023/7/1

UR - http://www.scopus.com/inward/record.url?scp=85160700183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160700183&partnerID=8YFLogxK

U2 - 10.1016/j.jceh.2023.05.009

DO - 10.1016/j.jceh.2023.05.009

M3 - Editorial

C2 - 37440937

AN - SCOPUS:85160700183

SN - 0973-6883

VL - 13

SP - 553

EP - 555

JO - Journal of Clinical and Experimental Hepatology

JF - Journal of Clinical and Experimental Hepatology

IS - 4

ER -

Real World Effectiveness of Atezolizumab and Bevacizumab: What Lessons Can We Learn?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this